Peripheral opioid receptor antagonist

This page covers all Peripheral opioid receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mu-opioid receptor (peripheral).

Targets

Mu-opioid receptor (peripheral)

Marketed (1)

• MOVANTIK™ (naloxegol) · Massachusetts General Hospital · Gastroenterology / Pain Management
  Naloxegol is a peripheral mu-opioid receptor antagonist that blocks opioid receptors in the gastrointestinal tract without crossing the blood-brain barrier, thereby reversing opioid-induced constipation.

Patent intelligence

• peripheral opioid receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates